NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Tenofovir Disoproxil Fumarate


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Forecast Insight Report: HIV - Cross-Class Fixed Dose Combinations Drive Continued Growth
2009 AUG 3 ... Reverse Transcriptase Inhibitor, Patents Actions, Pharmaceuticals, Protease Inhibitor, Tenofovir Disoproxil Fumarate, Therapy, Treatment, Truvada, Virology, Research and Markets. This article ...
Subject: Research and Markets
Price: $3.00
*
Gilead Announces Long-Term Data from Two Pivotal Phase III Studies Evaluating Viread(R) for Chronic Hepatitis B
2009 NOV 16 ... Studies 102 and 103, evaluating the safety and efficacy of once-daily Viread® (tenofovir disoproxil fumarate) among adult patients with chronic hepatitis B virus (HBV) infection. These data will be ...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Gilead Sciences Announces Record Second Quarter 2009 Financial Results
2009 AUG 3 ... the strong growth in sales of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), as well as continued growth in sales of Truvada® (emtricitabine...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Gilead Sciences Announces Record Third Quarter 2009 Financial Results
2009 NOV 2 ... the strong growth in sales of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) and continued growth in sales of Truvada® (emtricitabine...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring
2009 AUG 3 ... this study, 74 percent of patients were on a treatment regimen containing Viread® (tenofovir disoproxil fumarate). At baseline, more than 50 percent of patients had reduced renal function. The results ...
Subject: Gilead Sciences, Inc.
Price: $3.00
*
Mylan's Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
2009 AUG 31 ... Drug Application (ANDA) for a fixed-dose combination (FDC) of Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Tablets, 600 mg/200 mg/300 mg. This is the first and only generic version of this ...
Subject: HIV/AIDS
Price: $3.00
*
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets
2009 SEP 28 ... AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg. Mylan's product represents the first-ever ...
Subject: HIV/AIDS
Price: $3.00
*
NCCN Updates Infection Guidelines to Include Information About H1N1 Virus (Swine Flu)
2009 AUG 17 ... Ortho-McNeil-Janssen Pharmaceuticals, Inc.) to the Antibacterial Agents Tables and tenofovir disoproxil fumarate (Viread®, Gilead Sciences, Inc.) to the Antiviral Agents Tables. NCCN ...
Subject: Cancer
Price: $3.00
*
New findings reported from J.Y. Feng and co-authors describe advances in HIV/AIDS
2009 AUG 31 ... According to recent research from the United States, "Tenofovir disoproxil fumarate (TDF), emtricitabine (FTC), and efavirenz (EFV) are the three components of the ...
Subject: HIV/AIDS
Price: $3.00
*
New patents research from T. Amin and colleagues discussed
2009 OCT 5 ... do not conform to their laws. Using case-study examples, including the antiretroviral tenofovir disoproxil fumarate (TDF, or Viread), we demonstrate the importance of having outside experts participate in ...
Subject: Patents
Price: $3.00
*
New Results From ARTEN Study of Nevirapine Plus Tenofovir and Emtricitabine (TDF/FTC) Versus Boosted Protease Inhibitor Regimen of Atazanavir/Ritonavir Plus TDF/FTC Revealed
2009 AUG 3 ... Treatment, Emtricitabine, Pharmaceuticals, Drugs, Nevirapine, Ritonavir, Viramune, Tenofovir Disoproxil Fumarate, Truvada, Atazanavir, Anti-HIV, Antiviral, Nucleoside and Nucleotide Reverse ...
Subject: Boehringer Ingelheim Pharmaceuticals, Inc.
Price: $3.00
In Cart
Research from University of Basel reveals new findings on kidneys
2009 AUG 10 ... "Tenofovir disoproxil fumarate (tenofovir DF) use has been associated with renal dysfunction and Fanconi syndrome. ...
Subject: Kidneys
Price: $3.00
*
Research on HIV/AIDS published by D.A. Parks et al
2009 AUG 31 ... pharmacokinetic study in 12 HIV-infected patients stabilized on FPV/RTV 1400 mg/200 mg + tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) 300 mg/200 mg QD (TELEX 11)," scientists in the United States ...
Subject: HIV/AIDS
Price: $3.00
*
Research on HIV/AIDS reported by scientists at Columbia University
2009 AUG 24 ... after a prolonged course of vancomycin therapy in 2 patients who were receiving tenofovir disoproxil fumarate as part of an antiretroviral regimen Tenofovir has been implicated in the development of ...
Subject: HIV/AIDS
Price: $3.00
*
Studies from B.P. Kearney and colleagues reveal new findings on pharmacokinetics
2009 SEP 14 ... between a representative hormonal contraceptive (norgestimate-ethinyl estradiol) and tenofovir disoproxil fumarate (tenofovir DF), a prodrug of tenofovir, when coadministered. Thirty-day, open-label, ...
Subject: Pharmacokinetics
Price: $3.00
*
Studies from Chelsea and Westminster Hospital NHS Trust yield new information about HIV/AIDS
2009 SEP 14 ... of continuation of twice-daily zidovudine/lamivudine or replacement with once-daily tenofovir disoproxil fumarate/emtricitabine in individuals on successful efavirenz-based antiretroviral therapy," ...
Subject: HIV/AIDS
Price: $3.00
*
Studies from Imperial College provide new data on HIV/AIDS prevention
2009 AUG 3 ... Research findings, 'Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move ...
Subject: HIV/AIDS Prevention
Price: $3.00
*
Studies from L. Durandgasselin and colleagues reveal new findings on pharmaceuticals
2009 OCT 5 ... According to a study from the United States, "The antiviral drug tenofovir (TFV) is orally administered as the fumarate salt of its disoproxil prodrug (TFV ...
Subject: Pharmaceuticals
Price: $3.00
*
Study an Overview of the Key Companies Involved In the HIV Pipeline, Including an Analysis of the New Corporate Alliances
2009 NOV 9 ... Nucleoside Reverse Transcriptase Inhibitor, Pharmaceuticals, Protease Inhibitor, Tenofovir Disoproxil Fumarate, Therapy, Treatment, Truvada, Virology, Research and Markets. This article ...
Subject: Research and Markets
Price: $3.00
*
Study results from N.A. Margot and colleagues in the area of HIV/AIDS published
2009 NOV 9 ... Drug Resistance Through 144 Weeks in Antiretroviral-Naive Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934. ...
Subject: HIV/AIDS
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login